NCT03375320 2026-04-13Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsNational Cancer Institute (NCI)Phase 3 Active not recruiting298 enrolled 14 charts 3 FDA
NCT03891784 2026-01-14Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine TumorsUniversity of WashingtonPhase 2 Active not recruiting20 enrolled
NCT03600233 2025-12-23Study of CVM-1118 for Patients With Advanced Neuroendocrine TumorsTaiRx, Inc.Phase 2 Active not recruiting34 enrolled